BAH vs KTOS

The Advanced Deterministic Scorecard reveals a mixed financial profile for BAH, with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score to assess distress risk. Despite strong historical ROE of 75.2% and solid cash flow generation, the company faces significant headwinds with declining revenue and earnings, reflected in negative YoY growth of -8.1% and -52.9%, respectively. Valuation metrics suggest the stock is trading above its Graham Number of $35.57 and growth-based intrinsic value of $49.0, yet at a discount to sector peers on P/E. Analysts have a consensus 'hold' rating with a target price of $102.91, nearly at current levels, while technical trend signals remain bearish.

KTOS exhibits severe fundamental divergence, highlighted by a weak Piotroski F-Score of 2/9 and a massive valuation gap where the current price ($70.34) dwarfs the Graham Number ($5.88) and Intrinsic Value ($3.83). While the company shows strong top-line revenue growth (21.9%) and a consistent track record of earnings beats, its current P/E of 541.08 is unsustainable. The combination of bearish insider selling, a 0/100 technical trend, and razor-thin profit margins (1.63%) suggests the stock is priced for perfection in a high-risk environment.